Welcome to LookChem.com Sign In|Join Free

CAS

  • or
trans N-Benzyl Paroxetine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

105813-14-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 105813-14-7 Structure
  • Basic information

    1. Product Name: trans N-Benzyl Paroxetine
    2. Synonyms: trans N-Benzyl Paroxetine;(-)-N-Benzylparoxetine;(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-(phenylmethyl)-piperidine;(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine;Paroxetine EP Impurity C(N-Benzyl Paroxetine);Paroxetine hydrochloride EP impurity C
    3. CAS NO:105813-14-7
    4. Molecular Formula: C26H26FNO3
    5. Molecular Weight: 419.4879432
    6. EINECS: 929-011-7
    7. Product Categories: Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals
    8. Mol File: 105813-14-7.mol
    9. Article Data: 6
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 527.005°C at 760 mmHg
    3. Flash Point: 272.523°C
    4. Appearance: /
    5. Density: 1.216g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.596
    8. Storage Temp.: Refrigerator
    9. Solubility: N/A
    10. BRN: 9809201
    11. CAS DataBase Reference: trans N-Benzyl Paroxetine(CAS DataBase Reference)
    12. NIST Chemistry Reference: trans N-Benzyl Paroxetine(105813-14-7)
    13. EPA Substance Registry System: trans N-Benzyl Paroxetine(105813-14-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 105813-14-7(Hazardous Substances Data)

105813-14-7 Usage

Chemical Properties

Yellow-Thick Oil

Uses

Paroxetine intermediate

Check Digit Verification of cas no

The CAS Registry Mumber 105813-14-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,8,1 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 105813-14:
(8*1)+(7*0)+(6*5)+(5*8)+(4*1)+(3*3)+(2*1)+(1*4)=97
97 % 10 = 7
So 105813-14-7 is a valid CAS Registry Number.
InChI:InChI=1/C26H26FNO3/c27-22-8-6-20(7-9-22)24-12-13-28(15-19-4-2-1-3-5-19)16-21(24)17-29-23-10-11-25-26(14-23)31-18-30-25/h1-11,14,21,24H,12-13,15-18H2/t21-,24-/m0/s1

105813-14-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (Y0000579)  Paroxetine hydrochloride (anhydrous) impurity C  European Pharmacopoeia (EP) Reference Standard

  • 105813-14-7

  • Y0000579

  • 1,880.19CNY

  • Detail

105813-14-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S,4R)-1-benzyl-4-(4-fluorophenyl)-3-[3,4-(methylenedioxy)-phenoxymethyl]piperidine

1.2 Other means of identification

Product number -
Other names trans N-Benzyl Paroxetine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105813-14-7 SDS

105813-14-7Downstream Products

105813-14-7Relevant articles and documents

Enantioselective Synthesis of N-Alkylamines through β-Amino C-H Functionalization Promoted by Cooperative Actions of B(C6F5)3and a Chiral Lewis Acid Co-Catalyst

Chang, Yejin,Cao, Min,Chan, Jessica Z.,Zhao, Cunyuan,Wang, Yuankai,Yang, Rose,Wasa, Masayuki

supporting information, p. 2441 - 2455 (2021/02/16)

We disclose a catalytic method for β-C(sp3)-H functionalization of N-alkylamines for the synthesis of enantiomerically enriched β-substituted amines, entities prevalent in pharmaceutical compounds and used to generate different families of chiral catalysts. We demonstrate that a catalyst system comprising of seemingly competitive Lewis acids, B(C6F5)3, and a chiral Mg- or Sc-based complex, promotes the highly enantioselective union of N-alkylamines and α,β-unsaturated compounds. An array of δ-amino carbonyl compounds was synthesized under redox-neutral conditions by enantioselective reaction of a N-alkylamine-derived enamine and an electrophile activated by the chiral Lewis acid co-catalyst. The utility of the approach is highlighted by late-stage β-C-H functionalization of bioactive amines. Investigations in regard to the mechanistic nuances of the catalytic processes are described.

Catalytic Deuterium Incorporation within Metabolically Stable β-Amino C-H Bonds of Drug Molecules

Chang, Yejin,Yesilcimen, Ahmet,Cao, Min,Zhang, Yuyang,Zhang, Bochao,Chan, Jessica Z.,Wasa, Masayuki

supporting information, p. 14570 - 14575 (2019/10/11)

An efficient deuteration process of β-amino C-H bonds in various N-alkylamine-based pharmaceutical compounds has been developed. Catalytic reactions begin with the action of Lewis acidic B(C6F5)3 and Br?nsted basic N-alkylamine, converting a drug molecule into the corresponding enamine. The acid/base catalysts also promote the dedeuteration of acetone-d6 to afford a deuterated ammonium ion. Ensuing deuteration of the enamine then leads to the formation of β-deuterated bioactive amines with up to 99% deuterium incorporation.

Catalytic Michael/Ring-Closure Reaction of α,β-Unsaturated Pyrazoleamides with Amidomalonates: Asymmetric Synthesis of (?)-Paroxetine

Zhang, Yu,Liao, Yuting,Liu, Xiaohua,Yao, Qian,Zhou, Yuhang,Lin, Lili,Feng, Xiaoming

, p. 15119 - 15124 (2016/10/11)

A highly enantioselective tandem Michael/ring-closure reaction of α,β-unsaturated pyrazoleamides and amidomalonates has been accomplished in the presence of a chiral N,N′-dioxide–Yb(OTf)3complex (Tf: trifluoromethanesulfonyl) to give various substituted chiral glutarimides with high yields and diastereo- and enantioselectivities. Moreover, this methodology could be used for gram-scale manipulation and was successfully applied to the synthesis of (?)-paroxetine. Further nonlinear and HRMS studies revealed that the real catalytically active species was a monomeric L-PMe2–Yb3+complex. A plausible transition state was proposed to explain the origin of the asymmetric induction.

Highly enantioselective organocatalytic cascade reaction for the synthesis of piperidines and oxazolidines

?íhalová, Sylva,Valero, Guillem,Schimer, Ji?í,Humpl, Marek,Dra?ínsky, Martin,Moyano, Albert,Rios, Ramon,Vesely, Jan

, p. 8942 - 8950 (2011/12/01)

The synthesis of piperidines and piperidines derivatives in enantiopure fashion has been a challenging goal for organic chemists. In this report we developed a nice cascade reaction for piperidine derivatives based in an amidomalonate Michael addition to enals followed by an intramolecular hemiaminal formation with good yields and enantioselectivities. Moreover we studied the 'in situ' intramolecular cyclization of this hemiaminals with alcohols forming fused piperidine-oxazolidines.

Stereospecific construction of substituted piperidines. Synthesis of (-)-paroxetine and (+)-laccarin

Bower, John F.,Riis-Johannessen, Thomas,Szeto, Peter,Whitehead, Andrew J.,Gallagher, Timothy

, p. 728 - 730 (2007/10/03)

Short and efficient enantioselective syntheses of (-)-paroxetine and (+)-laccarin are described based on the highly stereospecific cleavage of C(3)-substituted 1,3-cyclic sulfamidates. The Royal Society of Chemistry.

Application of the chiral base desymmetrisation of imides to the synthesis of the alkaloid jamtine and the antidepressant paroxetine

Gill, Christopher D.,Greenhalgh, Daniel A.,Simpkins, Nigel S.

, p. 9213 - 9230 (2007/10/03)

The synthesis of the alkaloid jamtine and the antidepressant paroxetine have been addressed by a strategy involving asymmetric desymmetrisation of prochiral imides by a chiral lithium amide base. A short reaction sequence, starting with a cyclohexane fused succinimide, led to the structures originally reported for the alkaloid jamtine and its derived N-oxide. The structures synthesised are shown not to correspond with those originally reported. A second sequence involves desymmetrisation of a 4-arylglutarimide, and provides a short enantioselective synthesis of the drug substance paroxetine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105813-14-7